Effectiveness of Pfizer-BioNTech COVID-19 vaccine as evidence for policy action: A rapid systematic review and meta-analysis of non-randomized studies

In December 2020, an interim recommendation for the use of Pfizer-BioNTech COVID-19 vaccine in persons aged ≥16 years was made under Food and Drug Administration’s Emergency Use Authorization. In preparation for Biologics License Application approval, we conducted a systematic review and meta-analys...

Descripción completa

Detalles Bibliográficos
Autores principales: Wallace, Megan, Collins, Jennifer P., Moline, Heidi, Plumb, Ian D., Godfrey, Monica, Morgan, Rebecca L., Campos-Outcalt, Doug, Oliver, Sara E., Dooling, Kathleen, Gargano, Julia W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9725157/
https://www.ncbi.nlm.nih.gov/pubmed/36473010
http://dx.doi.org/10.1371/journal.pone.0278624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9725157/
https://www.ncbi.nlm.nih.gov/pubmed/36473010
http://dx.doi.org/10.1371/journal.pone.0278624

Ejemplares similares